BALSU’s most honest sentence does not stand beside chocolate customers, traceability, or the new plant in Chile. It stands in the trade payables note: as of March 31, 2026, there are 2.38 billion TL of hazelnuts received from sellers on consignment, not yet invoiced, used by the Group; the price will be paid at the rate prevailing on the payment date.
This does not make the company bad. It defines the company. At BALSU, the investment question is not whether hazelnuts are sold; it is at what maturity, at what exchange rate, and at what interest cost those hazelnuts are carried. Crushing capacity in Hendek and Ordu may be about 900 tons per day. By the end of 2024, with 49 thousand tons of sales volume, the company may have processed 13% of Turkey’s shelled hazelnut production. But what is bought on the exchange is not only a hazelnut factory; it is a maturity machine turning on inventory, receivables, supplier advances, bank debt, and currency risk.
In the interim period ended March 31, 2026, the table speaks two languages. The first is attractive: 15.27 billion TL net sales, 2.18 billion TL gross profit, 1.59 billion TL EBITDA, 10.43% EBITDA margin. The second is harsher: -160.8 million TL net loss for the period, -2.07 billion TL operating cash flow, 3.85 billion TL cash inflow from borrowings.
The Working Capital of Hazelnuts
Balsu’s business can sound narrow: buying, processing, and selling hazelnut products. But the product list is not narrow. Of nine-month revenue, 10.91 billion TL came from natural raw hazelnuts, 1.45 billion TL from in-shell hazelnuts, and 1.48 billion TL from hazelnut puree. Roasted kernels, granulated kernels, and hazelnut flour are smaller but higher-value pieces of the same table.
This machine generates high turnover, but carrying that turnover is expensive. Inventories rose from 4.08 billion TL on June 30, 2024 to 10.71 billion TL on March 31, 2026. Trade receivables rose in the same period from 1.52 billion TL to 8.27 billion TL. Trade payables jumped to 7.30 billion TL. Growth, in other words, is swelling not only the income statement but both sides of the balance sheet.
The critical detail is the entrusted hazelnut. The financial statements say 2.38 billion TL of trade payables relates to hazelnut purchases received on consignment but not yet invoiced. The same disclosure appears in the inventory note. These hazelnuts are being used by the Group; payment will be made at the price on the payment date. This may show BALSU’s strength in the supply chain. It also shows how price and maturity risk settle into the balance sheet.
Is There Cash As Well As EBITDA?
The interim activity report shows EBITDA of 1.59 billion TL. Read alone, that number can make the distance between market value and debt look digestible. But the cash flow statement objects. In the KAP financial-statement row set, operating activities used 2.07 billion TL of cash. The attached PDF presentation classifies a 311.3 million TL financial-investment cash-flow item differently, which makes operating cash flow appear as -2.38 billion TL and investing cash flow as -963 million TL there; this report uses the KAP table-row totals. Inventory growth absorbed 3.06 billion TL, trade receivables growth absorbed 3.87 billion TL, and the increase in other operating receivables absorbed 1.41 billion TL. Without the 6.06 billion TL rise in trade payables, the cash statement would have looked even more exposed.
| Item | 01.07.2025-31.03.2026 | Read-through |
|---|---|---|
| Net sales | TRY 15.27bn | The machine produces revenue. |
| EBITDA | TRY 1.59bn | 10.43% margin; activity report definition. |
| Net loss for the period | TRY -161m | Finance cost and working-capital pressure erase profitability. |
| Operating cash flow | TRY -2.07bn | Inventory and receivables, not profit, drive the story. |
| Investing cash flow | TRY -1.27bn | Hendex, capacity and related investments remain on the balance sheet. |
| Cash inflow from borrowings | TRY 3.85bn | The period was fueled by financing, not operations. |
That is why reading BALSU only through profit margin is a mistake. The company’s real heartbeat is heard not between gross profit and finance expense, but in whether inventory turns into receivables, receivables into cash, and cash into debt repayment.
Nine-month finance expense is 2.92 billion TL. Of this, 1.49 billion TL is interest expense and 987 million TL is foreign exchange loss. In the same period, a 947 million TL TAS 29 net monetary position gain entered the income statement. Without that accounting gain, the pre-tax loss would have looked much rougher. There is also 41.7 million TL of deferred tax income; there is no current-period corporate tax.
Flattening this table into “the company does not make money” would also be wrong. In the January-March 2026 column, net profit is 697.6 million TL. When price, inventory, and sales mix align correctly, the machine can produce earnings. The problem is this: the investor is buying not only the good quarter, but the nine-month cash cycle.
The Promise in the Shell
BALSU’s growth story looks in two directions: Chile and Hendex. In Chile, the target is a modern integrated hazelnut processing plant; the intended annual processing capacity is above 20 thousand tons. The interim activity report says land permits had been obtained as of April 2025 and that the plant will be announced on KAP if it is commissioned.
Hendex is more colorful. Activated carbon from hazelnut shells, energy from syngas, soil additive, and a claim of more than 100 thousand tons of annual shell-processing capacity. The incentive amount for the activated carbon investment has been raised to 3.07 billion TL. The first industrial line is planned to arrive in Turkey and be commissioned in the final quarter of 2026, with capacity above 20 thousand tons annually targeted between 2026 and 2028.
These are not trivial. In fact, this is the best part of the case for BALSU’s current valuation. Natural raw hazelnut sales are large, but they carry the smell of a commodity; if activated carbon can be produced from shells, the company may create a higher-margin side revenue stream from the same raw-material ecosystem. The rooftop solar system, with 1.919 MWp of total installed capacity, also covers an average of 32% of energy consumption.
But today’s price cannot be paid with tomorrow’s product launch. Hendex and Chile are not yet cash-flow-proven segments. Today’s balance sheet is using debt to carry tomorrow’s activated carbon.
The Family Table and Small Signals
The control side is simple: as of March 31, 2026, BG Holding holds 73.13% of the capital; publicly traded shares are 25%. Class B shares transferred to Genç Hayat Vakfı are 1.87%. The Board of Directors has six members, two of them independent. Salaries and wages provided to senior management and board members during the nine-month period were 59.7 million TL.
Related-party balances are not the main issue at this scale, but they should be read. There is a 32.3 million TL other receivable from BG Holding, a 3.8 million TL receivable from Muzaffer Taviloğlu, and a 6.9 million TL long-term receivable from Prfct Perakende. Related-party purchases include 321.1 million TL of goods purchased from Cuneyd Zapsu Danışmanlık A.Ş. and 21.4 million TL of consulting expense from Azizler Uluslararası Danışmanlık A.Ş. These amounts are not large enough by themselves to break the integrity of the balance sheet; but in a recently public, family-controlled company operating with heavy debt, they are lines that deserve a note.
The share buyback is a similar signal. Saying the price did not reflect real performance, the company reached a total of 3.15 million shares between March and May 2025; the ratio to capital is 0.283%. As a market message, it is understandable. As a financial effect, it remains small. What BALSU really needs to buy back is not the share, but the maturity inside its balance sheet.
| Risk | Sourced number | Why it matters |
|---|---|---|
| Consignment hazelnuts | TRY 2.38bn | Hazelnuts received and used will be paid to sellers at the payment-date price. |
| Bank debt within one year | TRY 10.94bn | If refinancing narrows, credit lines matter more than equity. |
| Net foreign-currency liability | TRY 6.59bn | A 10% FX move creates TRY 659m profit/loss sensitivity. |
| Net financial debt / capital employed | 76% | Balance-sheet flexibility depends on the working-capital cycle. |
| Management language versus cash truth | TRY 1.59bn EBITDA; TRY -2.07bn operating cash flow | EBITDA alone cannot carry the investment case. |
What Is the Price Paying For Up Front?
According to local market data on May 18, 2026, BALSU trades at 13.93 TL; its market value is 15.49 billion TL. Shareholders’ equity on March 31, 2026 was 4.40 billion TL. That means 3.5x P/BV. There is no cheapness in book value.
Enterprise value matters more. The capital risk table in the financial statement notes gives net financial debt as 13.92 billion TL. Added to market value, enterprise value reaches 29.41 billion TL. Nine-month EBITDA in the interim activity report is 1.59 billion TL; mechanically annualized, that becomes 2.12 billion TL. That means about 13.9x EV/EBITDA.
| Approach | Calculation | Read-through |
|---|---|---|
| Market value | TRY 13.93 price x 1.112bn shares = TRY 15.49bn | May 18, 2026 market data. |
| Net financial debt | TRY 14.29bn financial debt and lease liabilities less TRY 345m cash and TRY 30m financial investments = TRY 13.92bn | The balance sheet runs on debt larger than equity. |
| EV/EBITDA | TRY 29.41bn enterprise value / annualized TRY 2.12bn EBITDA = 13.9x | This multiple leaves little room for error for a commodity processor. |
| P/B | TRY 15.49bn market value / TRY 4.40bn equity = 3.5x | No book-value cheapness; the market prices growth optionality upfront. |
| Option sensitivity | If Hendex/Chile add TRY 600m sustainable EBITDA, EV/EBITDA falls to about 10.8x | That is not reported earnings yet; it is the future the price needs. |
The market’s belief is clear: debt will be rolled, working capital will unwind, Hendex and Chile will add a better margin to today’s commodity business. That belief is not impossible. But it is not free. The same company has 10.94 billion TL of bank debt maturing within one year. Net foreign currency liability is 6.59 billion TL; a 10% appreciation of foreign currencies against the TL, all else equal, creates a 659 million TL negative sensitivity on profit/loss and equity. Net financial debt to capital employed is 76%.
A stock is not cheap simply because it has fallen. BALSU’s IPO price was 17.57 TL; the latest market price is 13.93 TL. That alone is not cheapness. Because the post-IPO price decline does not automatically lower the enterprise value multiple; the debt is still on the table.
The Road Up
The strongest thing to write in BALSU’s favor is the scale and optionality of the business. It has a large hazelnut processing network in Turkey, global chocolate and confectionery customers, direct producer/wholesaler access, and foreign offices. When the right crop, the right pricing, and the right collection cycle arrive, Q1 net profit showed it: 697.6 million TL of profit could be written in a single quarter.
The proof for the upside case is clear. In the next financials, operating cash flow must turn positive. Net financial debt must come down meaningfully from 13.92 billion TL. Inventory and trade receivables growth must stop running faster than sales. Hendex’s first line must arrive without slipping from the final-quarter 2026 target. The Chile plant must show that it is an asset expanding supply geography, not a new debt step.
If this evidence arrives, today’s price may look early rather than expensive. Because if a commodity processor turns shells into a side pool of activated-carbon profit, the market may be willing to pay a different multiple.
The Road Down
The road down is quieter. It does not require a major scandal. A few more quarters of negative operating cash, a little more inventory, a little more receivables, a little more short-term credit, a little more foreign exchange loss would be enough. Then equity thins while EBITDA grows; revenue rises while cash goes to the bank.
This is the company-specific path of capital loss: not because BALSU cannot sell hazelnuts, but because the hazelnut must be carried until it is sold. If supplier maturities shorten, if bank interest remains hard, if the EUR position works against the company, or if the payment price of entrusted hazelnuts eats the margin, what falls to the shareholder is not growth but financing stress.
The anti-thesis must be fair: BALSU is not trash. Nor is it distressed. There is scale, there are customers, there are projects, there is Q1 profit. But today’s price behaves as if part of this evidence has already materialized. The most reliable evidence, however, is not yet in the cash flow statement.
Verdict
My verdict on BALSU is expensive.
This does not mean the company is bad. It means the price wants a brighter future than today’s balance sheet reality. A 3.5x book value multiple and a 13.9x annualized EBITDA multiple leave little room for error for a hazelnut processor burning -2.07 billion TL of operating cash, carrying 13.92 billion TL of net financial debt, and facing 10.94 billion TL of bank debt within one year.
This is not a stock to buy because “hazelnuts are a strong theme.” It is a stock for an investor willing to read the working-capital note, follow the crop cycle, count debt maturities, and wait for Hendex/Chile to turn from promise into cash. Owning BALSU today is not believing in the hazelnut itself; it is believing that the debt of entrusted hazelnuts will turn into cash.